Cullinan Therapeutics (NASDAQ:CGEM) just disclosed its Q4 earnings on Tuesday, March 10, 2026 at 07:00 AM.

Here's a brief overview of the earnings report.

Earnings

Cullinan Therapeutics beat estimated earnings by 6.1%, reporting an EPS of $-0.77 versus an estimate of $-0.82.

Revenue was down $0 from the same period last year.

Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.15, leading to a 2.18% drop share price change the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Cullinan Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.